About

Rachel Slade, Ph.D.

Patents, Publications, and Presentations

U.S. Patents (Inventor)

  • US 7,547,804, Compounds, Compositions, and Methods Employing Same
  • US 7,678,823, Compounds for Alzheimer's Disease
  • US 7,714,022, Pyrrole Derivatives as Therapeutic Compounds
  • US 7,842,805, Pharmaceutical Compounds as Activators of Caspases and Inducers of Apoptosis and the Use Thereof
  • US 8,217,073, Pyrrole Derivatives as Therapeutic Compounds       
  • US 9,034,871, Compounds for Alzheimer's Disease
  • US 9,216,966, Compounds for Alzheimer's Disease

 

Publications and Presentations

  • "Frontiers in Precision Medicine: Exploring Science and Policy Boundaries, Patenting Precision Medicine" Panelist, University of Utah, S.J. Quinney College of Law, 2015
  • "How Changes in the America Invents Act Affects Tech Companies" (author), The Enterprise Business Magazine, 2013
  • "Genetic Deficiency or Pharmacological Inhibition of Cyclooxygenase-1 or -2 Induces Mouse Keratinocyte Differentiation in vitro and in vivo" (coauthor), FASEB J, 1998
  • "Application of an Almost Traceless Linker to the Synthesis of 2-Alkylthiobenzimidazole Combinatorial Libraries" (coauthor), Molecular Diversity, 1998
  • "Application Cross-Coupling of Alkyl Cobaloximes with Maleic Anhydrides. Basic Studies and Applications to the Synthesis of Chaetomellic Acid A Anhydride and C-Glycosyl Maleic Anhydrides" (coauthor), Journal of Organic Chemistry, 1998
  • "Oxidative Addition of py(dmgH)2Co-Na+ to a Ribofuranosyl Bromide: An Unusual Reaction with the Cobaloxime Ligand" (coauthor), Organometallics, 1996
  • "A Radical Synthesis of Carbacephem Antibiotics and the Development of Cobaloxime-Mediated Syntheses of Substituted Maleic Anhydride Derivatives," Dissertation, University of Oregon, 1995
  • "A Cobaloxime-Mediated Synthesis of the Ras Farnesyl-Protein Transferase Inhibitor Chaetomellic Acid A" (coauthor), Tetrahedron Letters, 1994
  • "A Cobaloxime-Mediated Radical Route to Butenolides" (coauthor), Tetrahedron Letters, 1993